Faculty of Medical Laboratory Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Blood Transfus. 2011 Jul;9(3):301-5. doi: 10.2450/2011.0055-10. Epub 2011 Jan 13.
Thalassaemia is a genetic disease in which there is a relative or complete lack of alpha or beta globin chains. Patients with moderate to severe forms of thalassaemia need transfusions from the early years of life. Antibody production against blood group antigens may cause many problems in preparing compatible blood units for transfusion. The identification of definite blood group phenotypes by the haemagglutination method can be difficult because of the mixed population of red blood cells from the donor and recipient.
Forty multiply transfused thalassaemic patients and ten healthy controls with no history of blood transfusion were enrolled in this study. Allele-specific oligonucleotide polymerase chain reaction (ASO-PCR) and haemagglutination methods were used to determine the presence of Rhesus (Rh) C, c, E and e antigens.
In this study four primer sets were used for ASO-PCR amplification of RhC/c and RhE/e. Although PCR assays for RhC/c and RHE/e genotyping have been described previously, in this study we used a new condition for PCR by decreasing the annealing temperature from 63 °C to 58 °C in order to amplify all four genes in the same condition. In order to evaluate this single run molecular method, we used the haemagglutination test as the standard method and compared the results from the two methods. We found discrepancies between phenotype and genotype results among patients with beta thalassaemia, but complete agreement between phenotype and genotype in the control group.
The advantage of this new ASO-PCR method compared to a restriction fragment length polymorphism (RFLP) PCR method is that with the former all four genes can be amplified at the same time by PCR, and electrophoresis can be performed immediately to determine individual antigen profiles. The simplicity of the ASO-PCR method makes it suitable for routine use in medical centres and it is also cheaper than RFLP-PCR. Furthermore, as shown by previous studies, the results of haemagglutination and PCR tests often differ because the existence of donor red blood cells in the patient's circulation can interfere with the interpretation of the haemagglutination test.
地中海贫血是一种遗传性疾病,其中α或β球蛋白链相对或完全缺失。患有中重度地中海贫血的患者需要从生命早期开始输血。针对血型抗原的抗体产生可能会导致在为输血准备相容的血液单位时出现许多问题。由于供体和受者的红细胞混合人群,通过血凝法确定明确的血型表型可能会很困难。
本研究纳入了 40 名多次输血的地中海贫血患者和 10 名无输血史的健康对照者。使用等位基因特异性寡核苷酸聚合酶链反应(ASO-PCR)和血凝法来确定 Rh 因子 C、c、E 和 e 抗原的存在。
在本研究中,使用了四组引物进行 RhC/c 和 RhE/e 的 ASO-PCR 扩增。尽管以前已经描述了用于 RhC/c 和 RhE/e 基因分型的 PCR 检测,但在本研究中,我们使用了新的 PCR 条件,将退火温度从 63°C 降低至 58°C,以便在相同条件下扩增所有四个基因。为了评估这种单步分子方法,我们使用血凝法作为标准方法,并比较了两种方法的结果。我们发现β地中海贫血患者的表型和基因型结果之间存在差异,但对照组的表型和基因型完全一致。
与限制片段长度多态性(RFLP)PCR 方法相比,这种新的 ASO-PCR 方法的优势在于,使用前者可以通过 PCR 同时扩增所有四个基因,并立即进行电泳以确定个体抗原谱。ASO-PCR 方法的简单性使其适合在医疗中心常规使用,并且比 RFLP-PCR 更便宜。此外,正如先前的研究所示,由于受者循环中供体红细胞的存在会干扰血凝法的解释,因此血凝法和 PCR 检测的结果通常会有所不同。